Associated Papers
Comorbidities in Mild WAS/XLT Require Lifelong Follow-Up and Consideration of Definitive Treatment.
Mallebranche C et al.
American Journal of Hematology, 2025
Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.
Magnani A et al.
Nature Medicine, 2022
35075289 (PubMed )
Supplement: 41591_2021_1641_MOESM1_ESM.pdf
Targeted Gene Sanger Sequencing Should Remain the First-Tier Genetic Test for Children Suspected to Have the Five Common X-Linked Inborn Errors of Immunity.
Chan KW et al.
Frontiers in Immunology, 2022
A novel mutation W252X in the WAS gene in a Korean patient with Wiskott-Aldrich syndrome.
Kim HJ et al.
International Journal of Hematology, 2006
Detection of 28 novel mutations in the Wiskott-Aldrich syndrome and X-linked thrombocytopenia based on multiplex PCR.
Proust A et al.
Blood Cells, Molecules & Diseases, 0
Select a paper to view details